Address: Unit 606 SEDCCO 1 Bldg. cor. Rada & Legaspi Streets, Legaspi Village, Makati City,Philippines
Tel: +632 815-1209
In its early history, OEP Philippines, Inc. was known as Elan Pharma Phils., Inc. which was established in 1986. It was then acquired by Orient Europharma Ltd. of Taiwan in 2003.
OEP Philippines not only strives to meet the medical needs of Filipinos, but also supplies the country with affordable medicines to meet business objectives. OEP Philippines is currently cooperating closely with reputable business partners in product development and production, and searching for more opportunities in its product pipelines.
OEP Philippine subsidiary currently ranks at no. 24 among all ethical pharmaceutical companies in the Philippines and it is one of the fastest-growing and most rapid-expanding companies in the market. OEP Philippines expects the business to grow continuously by launching even more products in the years ahead.
OEP mission is to enhance the health and quality of life of the population of the Asian region through our entrepreneurial spirit by expertly managing our strategic partners’ and customers’ resources and by providing the public with innovative specialty health care products in the field of medicines, nutriments and dermo-cosmetics.
Over the next few years, Orient Europharma aims for recognition as a key player in the pharmaceutical industry in Asia: for its ongoing leadership in the marketing and sales of new products and cooperation with international research companies as well as product development.
OEP Philippines, the largest subsidiary in terms of sales revenue of Orient Europharma, is focused on marketing prescription medicines of a wide range of therapeutic classes, including anti-hypertensives, anti-anginals, anti-infectives and products for the treatment of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and allergic rhinitis. In 2008, the company successfully launched more pipeline extensions in the field of metabolism and anti-infectives to serve the market.
The product portfolio comprises active pharmaceutical ingredients (APIs) introduced for the very first time in the Philippines such as doxofylline, ebastine, erdosteine, nicorandil and nebivolol, as well as a number of unique specialty generic products and combinations thereof.
Mr. Chang, can you please give an overview of the establishment of OEP Philippines and the company’s current activities here? OEP Philippines started by acquiring the operations of Elan Pharma…
Lejal Laboratories has been founded in 1968 by your father. What have been the major milestones of the company since its founding and how has it evolved since you took…
Dr. Belo, you established the renowned Belo Medical group in 1990 with only a small clinic in Makati; since then the company has experienced strong growth and increased popularity. Looking…
In an exclusive interview, Benjamin Liuson, president of The Generics Pharmacy in the Philippines on the company’s illustrious history, remarkable growth, and increasing acceptance of generics more generally in the…
We have interviewed Novartis in several emerging markets including Colombia, Turkey, South Korea and Thailand. As the South East Asia Cluster Head, what is the importance of the South East…
You worked as a Country Manager in Indonesia and Thailand prior to joining IMS Health in the Philippines. What, in your opinion, sets this market apart? For starters, Indonesia is…
Given that Asia is leading growth in the global pharmaceutical market, how is Novo Nordisk represented in the Asia-Pacific region and what is the importance of the Philippines within the…
Interphil Laboratories has been active in the Philippines for a long time, having started in 1975 with the merger between Muller & Phipps. Can you give to our readers an…
GSK is currently the world’s fourth biggest pharmaceutical company. What is the positioning of GSK in the Philippines? GSK is the market leader among the multinational pharma companies in the…
Ms. Baua, you have been working for quite a long time in the Department of Trade and Industry. Can you please start by giving to our readers an overview of…
Ms. Tacandong, you assumed office as Director of the Bureau of Food and Drugs (BFAD) in June 2009, and two months later the BFAD became Food and Drug Administration (FDA)…
The Philippine Chamber of Pharmaceutical Industries was established in 2004 from the merger of four different associations (Chamber of Filipino Drug Manufacturers and Distributors, Association of Drug Industries of the…
Mr. Pagdanganan, you were appointed chairman of MeTA in April, after having served as Vice Chairman of the Council. Can you please begin by giving to our readers an overview…
See our Cookie Privacy Policy Here
